Nearly 7 million Americans are living with Alzheimer's disease and that number is projected to rise to nearly 13 million.

"By bringing Alzheimer's blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner." ...

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer's disease by measuring proteins linked to the condition. The new test, known ...

Medicare covers most types of blood tests that allow a healthcare professional to track your health and even screen for disease prevention. Coverage depends on meeting Medicare's eligibility criteria.